Canada Orphan Drugs Market (2025-2031) | Value, Industry, Outlook, Analysis, Revenue, Companies, Forecast, Size, Share, Segmentation, Trends & Growth

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Canada Country Macro Economic Indicators

3.2 Canada Orphan Drugs Market Revenues & Volume, 2021 & 2031F

3.3 Canada Orphan Drugs Market - Industry Life Cycle

3.4 Canada Orphan Drugs Market - Porter's Five Forces

3.5 Canada Orphan Drugs Market Revenues & Volume Share, By Drugs, 2021 & 2031F

3.6 Canada Orphan Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

3.7 Canada Orphan Drugs Market Revenues & Volume Share, By Therapy Class, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of rare diseases in Canada

4.2.2 Supportive government regulations and policies for orphan drugs

4.2.3 Growing focus on personalized medicine and targeted therapies

4.3 Market Restraints

4.3.1 High cost of orphan drugs leading to affordability issues

4.3.2 Limited awareness and access to orphan drugs in remote areas

4.3.3 Challenges in obtaining reimbursement for orphan drugs

6.1 Canada Orphan Drugs Market, By Drugs

6.1.1 Overview and Analysis

6.1.2 Canada Orphan Drugs Market Revenues & Volume, By Revlimid, 2021-2031F

6.1.3 Canada Orphan Drugs Market Revenues & Volume, By Rituxan, 2021-2031F

6.1.4 Canada Orphan Drugs Market Revenues & Volume, By Opdivo, 2021-2031F

6.1.5 Canada Orphan Drugs Market Revenues & Volume, By Keytruda, 2021-2031F

6.1.6 Canada Orphan Drugs Market Revenues & Volume, By Imbruvica, 2021-2031F

6.1.7 Canada Orphan Drugs Market Revenues & Volume, By Soliris, 2021-2031F

6.2 Canada Orphan Drugs Market, By Drug Type

6.2.1 Overview and Analysis

6.2.2 Canada Orphan Drugs Market Revenues & Volume, By Biologics, 2021-2031F

6.2.3 Canada Orphan Drugs Market Revenues & Volume, By Non-Biologics, 2021-2031F

6.3 Canada Orphan Drugs Market, By Therapy Class

6.3.1 Overview and Analysis

6.3.2 Canada Orphan Drugs Market Revenues & Volume, By Oncology, 2021-2031F

6.3.3 Canada Orphan Drugs Market Revenues & Volume, By Blood, 2021-2031F

6.3.4 Canada Orphan Drugs Market Revenues & Volume, By Endocrine, 2021-2031F

6.3.5 Canada Orphan Drugs Market Revenues & Volume, By Central Nervous Systems, 2021-2031F

6.3.6 Canada Orphan Drugs Market Revenues & Volume, By Cardiovascular, 2021-2031F

6.3.7 Canada Orphan Drugs Market Revenues & Volume, By Respiratory, 2021-2031F

7.1 Canada Orphan Drugs Market Export to Major Countries

7.2 Canada Orphan Drugs Market Imports from Major Countries

8.1 Number of orphan drug designations granted by Health Canada

8.2 Patient enrollment in clinical trials for orphan drugs

8.3 Percentage increase in funding for rare disease research and treatment

9.1 Canada Orphan Drugs Market Opportunity Assessment, By Drugs, 2021 & 2031F

9.2 Canada Orphan Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F

9.3 Canada Orphan Drugs Market Opportunity Assessment, By Therapy Class, 2021 & 2031F

10.1 Canada Orphan Drugs Market Revenue Share, By Companies, 2024

10.2 Canada Orphan Drugs Market Competitive Benchmarking, By Operating and Technical Parameters